Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Dart Xia Yan Venture Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 2
Rounds per year 0.67
Lead investments 0
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Medical
  • Manufacturing
  • Health Care

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Shengbao Bio

Biotechnology
Medical
Pharmaceutical
26 Jul 2024 Shenzhen, Guangdong, China

Full-Life Technologies

Health Care
Manufacturing
Pharmaceutical
$47M03 Jan 2024 Shanghai, Shanghai, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Dart Xia Yan Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 23M
Rounds per year 0.67
Peak activity year 2024
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Shengbao Bio

Biotechnology
Medical
Pharmaceutical
26 Jul 2024 Shenzhen, Guangdong, China

Full-Life Technologies

Health Care
Manufacturing
Pharmaceutical
$47M03 Jan 2024 Shanghai, Shanghai, China
Crunchbase icon

Content report

The following text will be sent to our editors: